News and breakthroughs in tissue analysis, biomarkers, and pathology technology.
Flagship Receives Accreditation from College of American Pathologists
Westminster, CO, April 10, 2018 – The Accreditation Committee of the College of American Pathologists (CAP) has awarded accreditation to Flagship Biosciences, based on results
Flagship Biosciences ActionAnalysis Solutions Accelerate Drug Development
Ready-to-use and custom image analysis meets current and future development needs Westminster, CO, February 12, 2018 – Flagship Biosciences is adding to its menu of
Flagship supports Summit Therapeutics advancement of DMD therapies
January 26, 2018 – Flagship is proud to partner with Summit Therapeutics in its efforts to advance therapies for patients with Duchenne Muscular Dystrophy (DMD).
Flagship Biosciences ActionAssays Deliver Actionable Data to Drive Immuno-Oncology Decisions
Comprehensive catalog of assays advance biomarker programs Westminster, CO, January 16, 2018 – Flagship Biosciences has introduced a new menu of services to help drug
Flagship Biosciences Presents PD-L1 Scoring Method at SITC 2017 that could Eliminate Reliance on Complex Multiplex IHC Assays
Novel cTA™-based morphometric biomarker interpretation approach quantifies immune cells in tumor tissues and has potential to revolutionize PD-L1 diagnostics landscape National Harbor, MD – November
Flagship Biosciences, Inc. Receives Prestigious Best Research Award for Poster on PD-L1 Harmonization at Pathology Visions 2017 Conference
Westminster, CO, Oct. 4, 2017 – Flagship Biosciences was honored to receive the award for Best Poster in the Research Category at the Pathology Visions
